首都医科大学学报 ›› 2010, Vol. 31 ›› Issue (4): 509-513.

• 重点学科与重点实验室介绍 • 上一篇    下一篇

多肽及小分子药物北京市重点实验室的五年——革新意识、钻研学问、训练人才状况分析

王玉记, 徐艳霞, 吴建辉, 赵明, 彭师奇*   

  1. 多肽及小分子药物北京市重点实验室, 首都医科大学化学生物学与药学院
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2010-08-21 发布日期:2010-08-21
  • 通讯作者: 彭师奇

The five years of the Beijing Area Major Laboratory of Peptide, Small Molecular Drugs: Progress in Refining Ideal, Deepgoing Research,and Training Successor

WANG Yu-ji, XU Yan-xia, WU Jian-hui, ZHAO Ming, PENG Shi-qi*   

  1. Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, College of Pharmaceutical Sciences, Capital Medical University
  • Received:1900-01-01 Revised:1900-01-01 Online:2010-08-21 Published:2010-08-21
  • Contact: PENG Shi-qi

摘要: 2005年,北京市教委在首都医科大学建立了多肽及小分子药物北京市重点实验室。本文分析了重点实验室在心脑血管药物研究、抗肿瘤药物研究和抗骨质疏松药物研究中的革新意识、钻研学问和训练人才的基本状况。

关键词: 药物研究, 人才培养, 重点实验室建设

Abstract: Beijing Area Major Laboratory of Peptide and Small Molecular Drugs has been established for five years. This paper reports the progress of this laboratory in the discovery of cardio-cerebral, anti-cancer and anti-osteoporosis drugs via the refining of the ideal, deepgoing of the research and training of the successor.

Key words: drug research, training successor, major laboratory

中图分类号: